We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy
CAT No: AAD-407
CAS No: 159857-79-1
Synonyms/Alias: Val-cit-PAB-OH;159857-79-1;Val-Cit-PAB;Val-cit-PAB-OH (GMP);L-Ornithinamide, L-valyl-N5-(aminocarbonyl)-N-[4-(hydroxymethyl)phenyl]-;(S)-2-((S)-2-amino-3-methylbutanamido)-N-(4-(hydroxymethyl)phenyl)-5-ureidopentanamide;(2S)-2-[[(2S)-2-amino-3-methylbutanoyl]amino]-5-(carbamoylamino)-N-[4-(hydroxymethyl)phenyl]pentanamide;MFCD22381209;(2S)-2-[(2S)-2-AMINO-3-METHYLBUTANAMIDO]-5-(CARBAMOYLAMINO)-N-[4-(HYDROXYMETHYL)PHENYL]PENTANAMIDE;(2S)-5-((aminocarbonyl)amino)-2-(((2S)-2-amino-3-methylbutanoyl)amino)-N-(4-(hydroxymethyl)phenyl)pentanamide;(2S)-5-[(aminocarbonyl)amino]-2-{[(2S)-2-amino-3-methylbutanoyl]amino}-N-[4-(hydroxymethyl)phenyl]pentanamide;SCHEMBL7607468;VEGGTWZUZGZKHY-GJZGRUSLSA-N;GLXC-25015;BCP16796;EX-A3307;L-valyl-N5-carbamoyl-N-[4-(hydroxymethyl)phenyl]-L-omithinamide;HY-12362G;AKOS027326644;L-valyl-N5-(aminocarbonyl)-N-[4-(hydroxymethyl)phenyl]-L-Ornithinamide;CS-5171;BP-23218;DA-48524;DS-12008;FV145679;HY-12362;CS-0899157;V0155;C70030;L-valyl-N~5~-carbamoyl-N-[4-(hydroxymethyl)phenyl]-L-omithinamide;L-valyl-N~5~-carbamoyl-N-[4-(hydroxymethyl)phenyl]-L-ornithinamide;(2S)-2-[[(2S)-2-amino-3-methyl-butanoyl]amino]-N-[4-(hydroxymethyl)phenyl]-5-ureido-pentanamide;826-617-2;
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C18H29N5O4 |
M.W/Mr. | 379.5 |
Sequence | One Letter Code:VX |
InChI | InChI=1S/C18H29N5O4/c1-11(2)15(19)17(26)23-14(4-3-9-21-18(20)27)16(25)22-13-7-5-12(10-24)6-8-13/h5-8,11,14-15,24H,3-4,9-10,19H2,1-2H3,(H,22,25)(H,23,26)(H3,20,21,27)/t14-,15-/m0/s1 |
InChI Key | VEGGTWZUZGZKHY-GJZGRUSLSA-N |
1. Myotropic activity of allatostatins in tenebrionid beetles
3. TMEM16F and dynamins control expansive plasma membrane reservoirs
4. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
5. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
Required fields are marked with *
×Required fields are marked with *
×If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.
USA
Address: SUITE 115, 17 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-624-4882
Fax: 1-631-614-7828
Email: info@creative-peptides.com
Germany
Address: Industriepark Höchst, Gebäude G830
65929 Frankfurt am Main
Email: info@creative-peptides.com